Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 2/20 | 0.52 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.49 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.45 |
| ▸ | BACE1 | P56817 | 5/20 | 0.45 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.45 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.45 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.45 |
| ▸ | BMP1 | P13497 | 1/20 | 0.44 |
| ▸ | CTSD | P07339 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29482767 | 1.00 | ECE1 (0.52) | ECE1NOD1ENPEPBACE1FOLH1 | |
| SCHEMBL3894744 | 0.93 | ECE1 (0.52) | ECE1NOD1ENPEPBACE1BMP1 | |
| SCHEMBL5324601 | 0.91 | ENPEP (0.53) | NOD1ENPEPFOLH1RIMKLANAALAD2 | |
| SCHEMBL31390152 | 0.91 | ECE1 (0.59) | ECE1NOD1ENPEP | |
| SCHEMBL31627965 | 0.90 | NOD1 (0.53) | NOD1FOLH1RIMKLANAALAD2BMP1 | |
| SCHEMBL29772065 | 0.90 | NOD1 (0.53) | NOD1FOLH1RIMKLANAALAD2BMP1 | |
| SCHEMBL30193304 | 0.90 | NOD1 (0.53) | NOD1FOLH1RIMKLANAALAD2BMP1 | |
| SCHEMBL30360301 | 0.89 | ECE1 (0.55) | ECE1NOD1ENPEP | |
| SCHEMBL30360348 | 0.89 | ECE1 (0.55) | ECE1NOD1ENPEP | |
| SCHEMBL28727840 | 0.89 | FOLH1 (0.56) | NOD1FOLH1RIMKLANAALAD2BMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12325760-B2 | Inhibitors of NF kappa-B activity for treatment of diseases and disorders | BHATNAGAR RAJENDRA SAHAI (US) | 2025-06-10 | — | — | US | claimed |
| US-20240180997-A1 | PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES | BHATNAGAR RAJENDRA SAHAI (US) | 2024-06-06 | — | — | US | claimed |
| US-20240083941-A1 | INHIBITORS OF NF KAPPA-B ACTIVITY FOR TREATMENT OF DISEASES AND DISORDERS | BHATNAGAR RAJENDRA SAHAI (US) | 2024-03-14 | — | — | US | claimed |
| EP-4203988-A2 | PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES | Bhatnagar, Rajendra, Sahai (US) | 2023-07-05 | — | — | EP | claimed |
| CN-114432423-A | NF for treating diseases and disorderskInhibitors of B activity | 拉金德拉·萨哈伊·巴特纳格尔 | 2022-05-06 | — | — | CN | claimed |
| US-20220133837-A1 | PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES | BHATNAGAR RAJENDRA SAHAI (US) | 2022-05-05 | — | — | US | claimed |
| WO-2022047225-A2 | PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES | BHATNAGAR RAJENDRA SAHAI (US) | 2022-03-03 | — | — | WO | claimed |
| WO-2007139433-A1 | PEPTIDE SUBSTANCE NORMALIZING THE METABOLISM IN OSSEOUS AND CARTILAGINOUS TISSUES, PHARMACEUTICAL COMPOSITION ON ITS BASE AND THE METHOD OF ITS APPLICATION | OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU "SIA PEPTIDES" (RU) | 2007-12-06 | — | — | WO | claimed |
| US-12325760-B2 | Inhibitors of NF kappa-B activity for treatment of diseases and disorders | BHATNAGAR RAJENDRA SAHAI (US) | 2025-06-10 | — | — | US | disclosed |
| US-20240180997-A1 | PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES | BHATNAGAR RAJENDRA SAHAI (US) | 2024-06-06 | — | — | US | disclosed |
| US-20240083941-A1 | INHIBITORS OF NF KAPPA-B ACTIVITY FOR TREATMENT OF DISEASES AND DISORDERS | BHATNAGAR RAJENDRA SAHAI (US) | 2024-03-14 | — | — | US | disclosed |
| US-11773135-B2 | Inhibitors of NF kappa-B activity for treatment of diseases and disorders | BHATNAGAR RAJENDRA SAHAI (US) | 2023-10-03 | — | — | US | disclosed |
| EP-4203988-A2 | PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES | Bhatnagar, Rajendra, Sahai (US) | 2023-07-05 | — | — | EP | disclosed |
| CN-114432423-A | NF for treating diseases and disorderskInhibitors of B activity | 拉金德拉·萨哈伊·巴特纳格尔 | 2022-05-06 | — | — | CN | disclosed |
| US-20220106359-A1 | INHIBITORS OF NF KAPPA-B ACTIVITY FOR TREATMENT OF DISEASES AND DISORDERS | BHATNAGAR RAJENDRA SAHAI (US) | 2022-04-07 | — | — | US | disclosed |
| WO-2022047225-A2 | PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES | BHATNAGAR RAJENDRA SAHAI (US) | 2022-03-03 | — | — | WO | disclosed |
| WO-2007139433-A8 | PEPTIDE SUBSTANCE NORMALIZING THE METABOLISM IN OSSEOUS AND CARTILAGINOUS TISSUES, PHARMACEUTICAL COMPOSITION ON ITS BASE AND THE METHOD OF ITS APPLICATION | OBSCHESTVO S OGRANICHENNOI OTV (RU) | 2009-07-16 | — | — | WO | disclosed |
| WO-2007139433-A1 | PEPTIDE SUBSTANCE NORMALIZING THE METABOLISM IN OSSEOUS AND CARTILAGINOUS TISSUES, PHARMACEUTICAL COMPOSITION ON ITS BASE AND THE METHOD OF ITS APPLICATION | OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU "SIA PEPTIDES" (RU) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007139433-A1 | PEPTIDE SUBSTANCE NORMALIZING THE METABOLISM IN OSSEOUS AND CARTILAGINOUS TISSUES, PHARMACEUTICAL COMPOSITION ON ITS BASE AND THE METHOD OF ITS APPLICATION | OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU "SIA PEPTIDES" (RU) | 2007-12-06 | — | — | WO | disclosed |
| US-4426324-A | Immunopotentiating peptides | HOFFMANN-LA ROCHE INC. (US) | 1984-01-17 | — | — | US | disclosed |